Previous studies have shown that long-term potentiation (LTP) can be induced in the lateral nucleus of the amygdala (LA) after stimulation of central auditory pathways and that auditory fear conditioning modifies neural activity in the LA in a manner similar to LTP. The present experiments examined whether intra-LA administration of inhibitors of protein synthesis or protein kinase A (PKA) activity, treatments that block LTP in hippocampus, interfere with memory consolidation of fear conditioning. In the first series of experiments, rats received a single conditioning trial followed immediately by intra-LA infusions of anisomycin (a protein synthesis inhibitor) or Rp-cAMPS (an inhibitor of PKA activity) and were tested 24 hr later. Results indicated that immediate post-training infusion of either drug dose-dependently impaired fear memory retention, whereas infusions 6 hr after conditioning had no effect. Additional experiments showed that anisomycin and Rp-cAMPS interfered with long-term memory (LTM), but not short-term memory (STM), of fear and that the effect on LTM was specific to memory consolidation processes rather than to deficits in sensory or performance processes. Findings suggest that the LA is essential for memory consolidation of auditory fear conditioning and that this process is PKA and protein-synthesis dependent.
Considerable progress has been made in identifying the neuroanatomical and cellular events underlying Pavlovian fear conditioning, particularly auditory fear conditioning, which is thought to involve alterations in synaptic transmission in the lateral nucleus of the amygdala (LA) (Davis, 1997; Fanselow and LeDoux, 1999; LeDoux, 2000) . Less is known, however, about the molecular mechanisms that underlie fear memory consolidation. It is thus of interest that long-term potentiation (LTP), the leading cellular model of memory consolidation in the mammalian brain, has been demonstrated in the LA both in vivo and in vitro after stimulation of central auditory pathways (Chapman et al., 1990; Clugnet and LeDoux, 1990; Rogan and LeDoux, 1995; Huang and Kandel, 1998; Weisskopf et al., 1999) . Furthermore, neural activity in the LA is modified during auditory fear conditioning in a manner similar to LTP (McKernan and Shinnick-Gallagher, 1997; Rogan et al., 1997) . These observations suggest that an LTP-like mechanism in the LA may underlie conditioned fear, which in turn suggests that memory consolidation of auditory fear in the LA and LTP may share a common molecular substrate.
Studies of LTP in the hippocampus have revealed two distinct temporal phases, each characterized by distinct molecular mechanisms. The "early" phase (E-LTP), lasting minutes to hours, does not require protein or RNA synthesis (Frey et al., 1993; Huang et al., 1994; Nguyen and Kandel, 1996) . The "late" phase (L-LTP), lasting hours to days, is dependent on RNA and protein synthesis and requires the cAMP-dependent protein kinase (PKA) (Frey et al., 1993; Huang et al., 1994; Nguyen and Kandel, 1996) . Application of RNA or protein synthesis inhibitors or inhibitors of PKA to hippocampal slices prevents the induction of L-LTP in both area CA1 and the dentate gyrus but has little effect on E-LTP (Frey et al., 1993; Nguyen and Kandel, 1996) . Furthermore, stimulation that leads to L-LTP transiently activates PKA (Roberson and Sweatt, 1996) and also induces the transcription of cAMP response element (CRE)-mediated genes, an effect that is prevented, along with LTP, by inhibitors of PKA (Impey et al., 1996) . These results suggest that PKA is necessary for the longterm protein synthesis-dependent changes that underlie L-LTP and, by implication, hippocampal-dependent memory consolidation (Milner et al., 1998) .
The results of several recent studies suggest that PKA activation and RNA and protein synthesis are also involved in fear memory consolidation. For example, blockade of PKA prevents LTP in the LA in vitro (Huang and Kandel, 1998) . Furthermore, fear memory consolidation is impaired in transgenic mice that overexpress an inhibitory isoform of PKA (Abel et al., 1997) and also after either systemic or intracerebroventricular administration of inhibitors of protein synthesis or PKA (Bourtchuladze et al., 1998; Schafe et al., 1999) . Finally, RNA synthesis inhibition in the amygdala has been shown to impair fear learning (Bailey et al., 1999) .
To determine whether PKA activation and protein synthesis in the amygdala are involved in fear memory consolidation, the present series of experiments used direct infusion of inhibitors of PKA and protein synthesis into the LA.
MATERIALS AND METHODS
Subjects. Subjects were adult male Sprague Dawley rats (Hilltop, Scottdale, PA). They were housed individually in plastic Nalgene cages and maintained on a 12 hr light /dark cycle. Food and water were provided freely throughout the experiment.
Surger y. Under Nembutal anesthesia (45 mg / kg), rats were implanted bilaterally with 22-gauge stainless steel cannulas into the L A. Coordinates, taken from Paxinos and Watson (1986) , were Ϫ3.0 anteroposterior, Ϯ5.3 mediolateral, and Ϫ8.0 mm dorsoventral. The cannulas were anchored to the skull with stainless steel screws and dental cement. A 28-gauge dummy cannula was inserted into each cannula to prevent clogging. After surgery, rats were given buprenorphine HC l (0.2 mg / kg, s.c.) as an analgesic. Rats were given at least 5 d to recover.
Habituation, conditioning, and microinf usion. On the day before conditioning, rats were habituated for 15 min to handling and to the conditioning (chamber A) and tone testing (chamber B) chambers [for details of the apparatus, see Schafe et al. (1999) ].
For conditioning, rats were placed in chamber A and given a single conditioning trial consisting of a 30 sec, 5 kHz, 75 dB tone that coterminated with a 2.0 mA, 1 sec footshock. Immediately after conditioning, rats were inf used with anisomycin (62.5, 6.2, or 0.62 g per side; 0.5 l), Rp-cAM PS (18, 1.8, or 0.18 g per side; 0.5 l), or artificial C SF (AC SF). Although the L A was the main target, the inf usions also likely affected the adjacent basal nucleus. We therefore refer to the affected area as the lateral and basal amygdala (L BA).
The highest dose of anisomycin was chosen based on a previous study showing Ͼ90% suppression of protein synthesis in cortex using this concentration (125 g/l) (Rosenblum et al., 1993) . The highest dose of Rp-cAM PS was chosen based on biochemical evidence indicating that this concentration of Rp-cAM PS effectively blocks PK A activity in vivo (Punch et al., 1997) .
Testing. LTM was evaluated the following day. For this test, rats were placed in chamber B and presented with five tones. Rats were videotaped during tone presentations for subsequent behavioral scoring.
Histolog y. Rats were anesthetized with an overdose of chloral hydrate (600 mg / kg, i.p.) and perf used with 10% buffered formalin. Brains were sectioned at 50 m and stained with cresyl violet. Sections were examined with light microscopy for cannula penetration into the L A.
RESULTS

Intra-LBA infusion of anisomycin or Rp-cAMPS dosedependently impairs the retention of auditory fear memory
Figure 1 A-D depicts mean auditory fear memory in rats injected with different doses of anisomycin, Rp-cAMPS, or ACSF. A and C depict mean percent freezing scores across each test trial. B and D depict mean percent freezing. For this latter measure, freezing scores were averaged across trials for each rat. For scoring, seconds freezing (of 30) were counted and expressed as a percentage of the total tone presentation time. All data were analyzed using ANOVA and Duncan's t tests.
Anisomycin
Relative to ACSF controls, rats infused with the highest dose of anisomycin had substantial memory impairment to the tone 24 hr after conditioning. The ANOVA revealed a significant group effect (F (3, 24) ϭ 10.49, p Ͻ 0.01) but a nonsignificant effect for trials and for the interaction. This same pattern of results is reflected in the mean tone memory scores (F (3, 24) ϭ 9.32, p Ͻ 0.01), where freezing after the highest dose of anisomycin differed from the ACSF group ( p Ͻ 0.05). Overall, no significant difference was detected between the ACSF and the low or medium dose groups. The amount of freezing demonstrated by rats in the highest dose group (ϳ30%) is roughly equivalent to that observed in groups receiving unpaired presentations of tones and shocks in a previous study from our lab using a similar single-trial training protocol (Schafe et al., 1999) .
Rp-cAMPS
The pattern of results for Rp-cAMPS was similar to that of anisomycin. The ANOVA revealed a significant group effect (F (3,27) ϭ 11.06, p Ͻ 0.01), a significant effect for trials (F (4,108) ϭ 3.93, p Ͻ 0.01), and a nonsignificant interaction. The same effect was observed for mean tone memory scores (F (3,27) ϭ 11.06, p Ͻ 0.01), where freezing after administration of the highest dose of Rp-cAMPS was found to differ from the ACSF group ( p Ͻ 0.05). Overall, no significant differences were detected between the ACSF and the two lower-dose groups.
Furthermore, rats receiving the highest dose of either anisomycin or Rp-cAMPS were able to reacquire fear when they were reconditioned drug-free ϳ1 week later ( Fig. 1 E, F ) . The ANOVA revealed no significant effects. Thus, administration of anisomycin or Rp-cAMPS does not appear to result in permanent inability to express fear or to associate tones and shocks, suggesting that amygdala function is not permanently impaired by these compounds.
To determine whether the amnesic effects of anisomycin and Rp-cAMPS were caused by impairment of memory consolidation processes in the LBA, three additional experiments were conducted (Fig. 2) . First, infusion of the highest doses of anisomycin or Rp-cAMPS 24 hr before conditioning had no effect on the Figure 1 . Impaired long-term fear retention after intra-LBA administration of different doses of anisomycin or Rp-cAMPS. A, Mean (ϮSE) LTM across all five trials in rats injected with ACSF (n ϭ 12; black squares), 0.62 g (n ϭ 4; white triangles), 6.25 g (n ϭ 4; light gray triangles), or 62.5 g anisomycin (n ϭ 9; dark gray triangles). B, Mean (ϮSE) LTM averaged across all trials for all anisomycin-treated groups. C, Mean (ϮSE) LTM across all five trials in rats injected with ACSF (n ϭ 12; black squares), 0.18 g (n ϭ 4; white triangles), 1.80 g (n ϭ 4; light gray triangles), or 18.0 g Rp-cAMPS (n ϭ 12; dark gray triangles). D, Mean (ϮSE) LTM averaged across all trials for all Rp-cAMPS-treated groups. E, Mean (ϮSE) LTM across all five trials in rats reconditioned drug-free ϳ1 week later. ACSF-, anisomycin-, and Rp-cAMPS-treated groups are represented by black squares, gray triangles, and white triangles, respectively. F, Mean (ϮSE) LTM averaged across all trials for all reconditioned groups. *p Ͻ 0.05 relative to ACSF controls. expression of STM 1 hr after training, which was assessed at approximately the same time as LTM in the previous experiments (Fig. 2 A, B) . Thus, it is unlikely that the freezing deficits observed in the LTM test are caused by some nonspecific effect of anisomycin or Rp-cAMPS on general activity levels (i.e., hyperactivity) 24 hr after the infusion. Second, infusion of the highest doses of anisomycin or Rp-cAMPS 2 mm above the LBA had no effect on fear retention (Fig. 2C,D) . Thus, the behavioral effects of each drug cannot be attributed to diffusion into the striatum or adjacent cortical areas dorsal to the rhinal fissure. Third, consistent with the time-limited role of memory consolidation processes (Davis and Squire, 1984) and with a recent paper showing no effect of systemic or intracerebroventricular infusions of anisomycin or Rp-cAMPS 6 hr after training (Bourtchuladze et al., 1998) , intra-LBA infusions of either drug 6 hr after training had no effect on fear retention (Fig. 2 E, F ) . Collectively, findings strongly favor the conclusion that anisomycin and Rp-cAMPS impair fear memory retention by blocking memory consolidation processes.
Intra-LBA infusion of anisomycin or Rp-cAMPS impairs LTM, but not STM, of auditory fear conditioning
In the first series of experiments, auditory fear memory was assessed 24 hr after conditioning. To more directly evaluate the possibility that anisomycin and Rp-cAMPS produced their effects on fear memory by interfering with memory consolidation processes, the final experiment evaluated both STM and LTM in the same animals.
Before performing the experiment, pilot studies were conducted to determine the optimal time point to assay for STM of auditory fear using our one-trial conditioning and post-training infusion paradigm. We found that administration of the highest dose of anisomycin (62.5 g per side) produced what appeared to be performance deficits (i.e., rats were unable to freeze) in auditory fear at 1 hr, but not at 4 hr, after conditioning and infusion, presumably because of temporary disruption of sensory transmission in the amygdala. Furthermore, the highest dose of Rp-cAMPS (18 g) was observed to impair auditory fear memory at both 1 and 4 hr after infusion. We therefore reduced the dose of Rp-cAMPS to 9 g per side, which was observed to be without significant effect on auditory STM 4 hr after training and drug infusion.
Rats were given one-trial auditory fear conditioning and infused immediately thereafter as in the initial experiments. Four hours later, rats were placed in chamber B and given three exposures to the tone. Approximately 24 hr later, rats were evaluated for LTM to the tone as in the previous experiments.
Percent freezing across each trial for tone STM and LTM scores is presented in Figure 3 , A and B, respectively, and mean relative memory scores for each group are presented in Figure   Figure 2 . Specificity of the effects of intra-LBA anisomycin and RpcAMPS. A, Mean (ϮSE) STM across all five trials in rats infused with ACSF (n ϭ 6), 18.0 g Rp-cAMPS (n ϭ 6), or 62.5 g anisomycin (n ϭ 6) 24 hr before conditioning. B, Mean (ϮSE) STM averaged across all trials for all groups infused 24 hr before conditioning. C, Mean (ϮSE) LTM across all five trials in rats infused with ACSF (n ϭ 4), 18.0 g Rp-cAMPS (n ϭ 4), or 62.5 g anisomycin (n ϭ 4) 2 mm dorsal to the LBA. D, Mean (ϮSE) LTM averaged across all trials for all dorsal controls. E, Mean (ϮSE) LTM across all five trials in rats infused with ACSF (n ϭ 6), 18.0 g Rp-cAMPS (n ϭ 6), or 62.5 g anisomycin (n ϭ 6) 6 hr after conditioning. B, Mean (ϮSE) LTM averaged across all trials for all groups infused 6 hr after conditioning. In each figure, ACSF is represented by black squares, anisomycin by gray triangles, and Rp-cAMPS by white triangles. Figure 3 . Impaired LTM, but not STM, after intra-LBA infusion of anisomycin or Rp-cAMPS. A, Mean (ϮSE) STM across all three trials in rats infused with ACSF (n ϭ 5), 62.5 g anisomycin (n ϭ 5), or 9 g Rp-cAMPS (n ϭ 5). B, Mean (ϮSE) LTM across all five tone test trials in rats injected with ACSF, anisomycin, or Rp-cAMPS. Rats injected with anisomycin both immediately after training and 4 hr before LTM testing (n ϭ 6) are represented by gray squares. C, Mean (ϮSE) percent of STM for rats injected with either ACSF, anisomycin, or Rp-cAMPS. *p Ͻ 0.05 relative to ACSF. In each figure, ACSF is represented by black squares, anisomycin by gray triangles, and Rp-cAMPS by white triangles.
3C. For this latter measure, LTM scores were calculated as a percentage of STM scores for each rat. Baseline freezing during the 30 sec period just before the first tone presentation in the STM test was negligible and was not found to differ between groups (ACSF: 6.4 Ϯ 3.3%; anisomycin: 4.6 Ϯ 3.8%; Rp-cAMPS: 7.8 Ϯ 4.4%). Thus, fear did not generalize from chamber A to chamber B.
The ANOVA for STM scores revealed a nonsignificant group effect, a nonsignificant effect of trials, and a nonsignificant interaction. The ANOVA for LTM scores, however, showed a significant group effect (F (2,12) ϭ 16.60, p Ͻ 0.01), a significant effect of trials (F (4,48) ϭ 5.39, p Ͻ 0.01), and a nonsignificant interaction. Overall, this same pattern of results is reflected in the relative memory scores (F (2,12) ϭ 11.10, p Ͻ 0.01), where both the anisomycin-and Rp-cAMPS-infused groups showed significant memory impairment relative to ACSF controls ( p Ͻ 0.05). No significant difference was detected between anisomycin and RpcAMPS groups. Thus, immediate post-training infusion of anisomycin or Rp-cAMPS into LBA impairs LTM of auditory fear conditioning, whereas it leaves STM intact. Finally, to rule out possible state-dependent influences that may have contributed to intact fear memory at 4 hr, we took an additional group of rats and infused them with anisomycin both immediately after training and 4 hr before LTM testing on the following day. If STM 4 hr after training was caused by statedependent influences, then, by implication, LTM in these rats should be intact. Findings indicated that it was not (Fig. 3B ). An ANOVA comparing LTM scores between anisomycin-treated rats tested drug-free and those tested under the influence of anisomycin showed no significant differences. Thus, it cannot be concluded that impaired LTM (or intact STM) was caused by state-dependent drug effects.
Histology
Cannula placements are shown in Figure 4 , A and B. Cannula tips were observed throughout the LBA. Only rats with cannula tips at or within the boundaries of LBA were included in the data analysis. Results of cannula tip analysis are shown only for the first two experiments in which rats were injected with different doses of anisomycin or Rp-cAMPS.
DISCUSSION
Evidence has suggested that the LBA is the site of the plastic changes underlying auditory fear conditioning. In support of this hypothesis, either permanent lesions or reversible functional inactivation of the LBA has been shown to eliminate auditory fear conditioning Wilensky et al., 2000) . Furthermore, cells in the LA have been shown to respond to both auditory and somatosensory stimuli (Romanski et al., 1993) and to receive projections from the auditory thalamus and cortex (LeDoux et al., 1991) . Importantly, LTP has been demonstrated in each of these pathways (Chapman et al., 1990; Rogan and LeDoux, 1995) , and auditory fear conditioning has been shown to modify neural activity in the LA in a manner similar to LTP induction (McKernan and Shinnick-Gallagher, 1997; Rogan et al., 1997) . These observations suggest that an LTP-like mechanism underlies fear acquisition in the LBA and thus that fear memory consolidation in the LBA and LTP may be characterized by common molecular mechanisms. In support of this hypothesis, findings of the present experiments indicate that auditory fear memory consolidation is dose-dependently disrupted by intra-LBA administration of inhibitors of protein synthesis and PKA. This pattern of findings is consistent with the LTP literature in which pharmacological disruption of both protein synthesis and PKA has been shown to selectively block hippocampal L-LTP, whereas it has little effect on E-LTP (Frey et al., 1993; Nguyen and Kandel, 1996) . It is also consistent with a recent study demonstrating a role for PKA in amygdala LTP (Huang and Kandel, 1998) . Collectively, results suggest that fear memory consolidation in the LA and LTP may share a common molecular substrate.
Several recent studies using either transgenic methods or systemic or intracerebroventricular administration of drugs have implicated protein synthesis or PKA, or both, in fear memory consolidation (Abel et al., 1997; Bourtchuladze et al., 1998; Schafe et al., 1999) . In contrast to these previous studies, the present study evaluated the role of protein synthesis and PKA specifically in the LBA. Intra-LBA administration of inhibitors of protein synthesis or PKA dose-dependently disrupted LTM of Pavlovian fear conditioning when given immediately after, but not 6 hr after, conditioning. Furthermore, controls suggested that the effect was localized to the amygdala and specific to memory consolidation rather than to sensory or performance processes. When considered together with the results of a recent report which showed that RNA synthesis inhibition in the LBA impairs fear memory (Bailey et al., 1999) , the accumulating evidence favors the view that fear memory consolidation requires PKAdependent gene expression and protein synthesis in the amygdala.
Although the present study did not evaluate the full time course of the effects of administration of anisomycin and RpcAMPS on fear memory, it is of interest that STM of auditory (dark gray triangles) . B, Cannula tip placements from rats infused with ACSF (black squares), 0.18 g Rp-cAMPS (white triangles), 1.80 g Rp-cAMPS (light gray triangles), or 18.0 g Rp-cAMPS (dark gray triangles). Adapted from Paxinos and Watson (1986) .
